Education
About Us
Working with TipRanks
Follow Us
Hansoh Pharmaceutical Group Company Limited (HK:3692)
:3692
RESEARCH TOOLSreports
Total Valuation
Hansoh Pharmaceutical Group Company Limited has a market cap or net worth of HK$135.33B. The enterprise value is HK$77.81B.
Market CapHK$135.33B
Enterprise ValueHK$77.81B
Share Statistics
Hansoh Pharmaceutical Group Company Limited has 5.94B shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5.94B
Owned by Insiders
Owned by Instutions
Financial Efficiency
Hansoh Pharmaceutical Group Company Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per EmployeeHK$1,345,877.183
Profits Per EmployeeHK$524,438.758
Employee Count8,989
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Hansoh Pharmaceutical Group Company Limited is ―. Hansoh Pharmaceutical Group Company Limited’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Hansoh Pharmaceutical Group Company Limited had revenue of HK$12.10B and earned HK$4.71B in profits. Earnings per share was HK$0.76.
RevenueHK$12.10B
Gross ProfitHK$11.01B
Operating IncomeHK$4.33B
Pretax IncomeHK$5.38B
Net IncomeHK$4.71B
EBITDA4.61B
Earnings Per Share (EPS)0.76
Cash Flow
In the last 12 months, operating cash flow was HK$4.65B and capital expenditures -HK$228.81M, giving a free cash flow of HK$4.42B billion.
Operating Cash FlowHK$4.65B
Free Cash FlowHK$4.42B
Free Cash Flow per ShareHK$0.75
Dividends & Yields
Hansoh Pharmaceutical Group Company Limited pays an annual dividend of HK$0.14, resulting in a dividend yield of 1.55%
Dividend Per ShareHK$0.14
Dividend Yield1.55%
Payout Ratio18.18%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.84
52-Week Price Change41.06%
50-Day Moving Average19.98
200-Day Moving Average18.67
Relative Strength Index (RSI)52.65
Average Volume (3m)12.53M
Important Dates
Hansoh Pharmaceutical Group Company Limited upcoming earnings date is Aug 27, 2025, TBA.
Last Earnings DateMar 21, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend DateJul 3, 2025
Financial Position
Hansoh Pharmaceutical Group Company Limited as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Hansoh Pharmaceutical Group Company Limited has paid HK$670.28M in taxes.
Income TaxHK$670.28M
Effective Tax Rate―
Enterprise Valuation
Hansoh Pharmaceutical Group Company Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Hansoh Pharmaceutical Group Company Limited has HK$23.50B in cash and marketable securities with HK$119.67M in debt, giving a net cash position of -HK$23.38B billion.
Cash & Marketable SecuritiesHK$23.50B
Total DebtHK$119.67M
Net Cash-HK$23.38B
Net Cash Per Share-HK$3.94
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Hansoh Pharmaceutical Group Company Limited is HK$26.23, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetHK$26.23
Price Target Upside18.42%
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast
EPS Growth Forecast